ERJ
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Permissions
Right arrowRequest Permissions
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Veale, D
Right arrow Articles by Cardinaud, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Veale, D
Right arrow Articles by Cardinaud, J.
Eur Respir J 1998; 12: 780-784
Copyright © ERS Journals Ltd 1998


Original Articles

Characteristics and survival of patients prescribed long-term oxygen therapy outside prescription guidelines

D Veale, E Chailleux, A Taytard, and JP Cardinaud

Criteria for the prescription of long-term oxygen therapy (LTOT) have been published by academic societies and regulatory bodies, but many prescriptions for LTOT do not fulfil these criteria. Demographic, functional data and survival were compared in chronic obstructive pulmonary disease (COPD) patients with different levels of oxygenation, i.e. arterial oxygen tension (Pa,O2) < 8 kPa or > or = 8 kPa (60 mmHg), at the time of initial registration in the ANTADIR Observatory. Data were collected between 1984-1995. Selection criteria were a diagnosis of COPD or emphysema with forced expiratory volume in one second (FEV1) < 80% pred, FEV1/vital capacity (VC) < 70% and age between 18-75 yrs. Of 7,700 patients prescribed LTOT 18.5% had stable Pa,O2 > or = 8 kPa. While the FEV1 was the same they differed from the patients with more severe hypoxaemia in having a higher rate of diagnosis of primary emphysema and a lower arterial carbon dioxide tension (Pa,CO2). In this group of patients LTOT was more frequently administered as liquid oxygen than in other patients on LTOT. The survival of these patients was reduced compared to the general population of the same age and sex but comparable to that of patients with a Pa,O2 between 6.7-8 kPa (50-60 mmHg). Patients prescribed long-term oxygen therapy with an arterial oxygen tension > or = 8 kPa (60 mmHg) in the ANTADIR network were shown to have severe chronic obstructive pulmonary disease on the basis of spirometry and their survival was similar to that of more hypoxaemic patients. Randomized controlled trials of the effect of long-term oxygen therapy in patients with arterial oxygen tension > or = 8 kPa are needed.


This article has been cited by other articles:


Home page
ChestHome page
O. R. d'Orbcastel, A. I. Goldberg, and M. Stuart
French Health System: More Work Is Needed
Chest, November 1, 2004; 126(5): 1710 - 1712.
[Full Text] [PDF]


Home page
ChestHome page
K. Fujimoto, Y. Matsuzawa, S. Yamaguchi, T. Koizumi, and K. Kubo
Benefits of Oxygen on Exercise Performance and Pulmonary Hemodynamics in Patients With COPD With Mild Hypoxemia*
Chest, August 1, 2002; 122(2): 457 - 463.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
P.J. Wijkstra, G.H. Guyatt, N. Ambrosino, B.R. Celli, R. Guell, J.F. Muir, C. Prefaut, E.S. Mendes, I. Ferreira, P. Austin, et al.
International approaches to the prescription of long-term oxygen therapy
Eur. Respir. J., December 1, 2001; 18(6): 909 - 913.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1998 by the European Respiratory Society.